4.5 Article

Inhibition of the Clostridioides difficile Class D β-Lactamase CDD-1 by Avibactam

Journal

ACS INFECTIOUS DISEASES
Volume 7, Issue 5, Pages 1164-1176

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsinfecdis.0c00714

Keywords

Clostridioides difficile; beta-lactamase; avibactam; kinetics; inhibition; crystal structure

Funding

  1. National Institutes of Health [R01AI114668-06]
  2. University of Notre Dame Equipment Restoration and Renewal (ERR) program
  3. Department of Energy (BES, BER)
  4. National Institutes of Health (NCRR, BTP, NIGMS)
  5. NCRR, a component of the National Institutes of Health [5 P41 RR001209]

Ask authors/readers for more resources

Avibactam is a potent irreversible mechanism-based inhibitor of class A and C beta-lactamases, with variable activity against some class D enzymes from Gram-negative bacteria. The interaction of avibactam with recently discovered class D beta-lactamases from Gram-positive bacteria has not been studied. X-ray crystallographic studies demonstrate the rapid formation of a stable CDD-1-avibactam acyl-enzyme complex and differences in anchoring of the inhibitor by class D enzymes from Gram-positive and Gram-negative bacteria.
Avibactam is a potent diazobicyclooctane inhibitor of class A and C beta-lactamases. The inhibitor also exhibits variable activity against some class D enzymes from Gram-negative bacteria; however, its interaction with recently discovered class D beta-lactamases from Gram-positive bacteria has not been studied. Here, we describe microbiological, kinetic, and mass spectrometry studies of the interaction of avibactam with CDD-1, a class D beta-lactamase from the clinically important pathogen Clostridioides difficile, and show that avibactam is a potent irreversible mechanism-based inhibitor of the enzyme. X-ray crystallographic studies at three time-points demonstrate the rapid formation of a stable CDD-1-avibactam acyl-enzyme complex and highlight differences in the anchoring of the inhibitor by class D enzymes from Gram-positive and Gram-negative bacteria.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available